Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular Markers of Steroid Resistance in Nasal Polyposis
NCT01616160Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2013
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mometasone in nasal polyps, sponsored by Massachusetts General Hospital. Started Jul 2013; status: terminated.
02
Drugs
mometasone
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT01616160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616160.